Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity (Details)

v3.25.2
Stockholders' Equity (Details)
6 Months Ended
Apr. 07, 2025
shares
Mar. 12, 2025
USD ($)
$ / shares
shares
Oct. 17, 2024
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
Mar. 31, 2025
USD ($)
shares
Dec. 31, 2024
$ / shares
shares
Oct. 31, 2024
shares
Oct. 07, 2024
$ / shares
Dec. 31, 2023
$ / shares
shares
Dec. 16, 2020
$ / shares
shares
Stockholders' Equity                      
Preferred stock authorized (in shares)               2,000,000   2,000,000  
Preferred stock, par value (in dollars per share) | $ / shares                   $ 0.0001  
Temporary equity, shares authorized       2,270     2,270        
Temporary equity, shares issued       2,269.1494     2,213.8044        
Temporary equity, shares outstanding       2,269.1494     2,213.8044        
Dividends payable | $           $ 1,770,767          
Common stock authorized (in shares)       43,000,000     43,000,000       43,000,000
Common stock, par value (in dollars per share) | $ / shares       $ 0.0001     $ 0.0001       $ 0.0001
Net proceeds from issuance of common stock | $       $ 4,252,245 $ 1,452,397            
Preferred Stock Excluding Series A and Series A-1 Non-Voting Convertible Preferred Stock                      
Stockholders' Equity                      
Preferred stock authorized (in shares)       1,997,446     1,997,730        
Preferred stock, par value (in dollars per share) | $ / shares       $ 0.0001     $ 0.0001        
Preferred stock issued (in shares)       0     0        
Preferred stock outstanding (in shares)       0     0        
Series A Non-Voting Convertible Preferred Stock                      
Stockholders' Equity                      
Temporary equity, shares authorized       2,270     2,270 2,270      
Temporary equity, shares issued       2,269.1494     2,213.8044        
Temporary equity, shares outstanding       2,269.1494              
Percentage of original shares remaining issued and outstanding       30.00%              
Shares automatically converted       10,000              
Preferred Stock                      
Stockholders' Equity                      
Preferred stock dividend rate percentage       5.00%              
Preferred stock dividend payment period 180 days     180 days              
PIK dividend, shares 55.345                    
Series A1 Convertible Preferred Stock                      
Stockholders' Equity                      
Preferred stock authorized (in shares)       284.2638   284.2638 0        
Preferred stock, par value (in dollars per share) | $ / shares   $ 0.0001                  
Preferred stock issued (in shares)       284.2638     0        
Preferred stock outstanding (in shares)       284.2638     0        
Minimum percentage of Preferred stock issued and outstanding       30.00%              
No. of share issued during conversion   10,000   10,000              
Pharmagesic Holdings Inc.                      
Stockholders' Equity                      
Preferred stock, par value (in dollars per share) | $ / shares                 $ 0.0001    
Number of Contingent Value Rights Issuable for each Common Share     1                
Contingent value rights agreement term     7 years                
Percentage of upfront payment to which holders are entitled     87.75%                
Percentage ownership of outstanding rights that entitles holder to audit and enforcement     30.00%                
Registered Direct Offering                      
Stockholders' Equity                      
Shares issued   578,950                  
Price per share | $ / shares   $ 8.26                  
Gross proceeds from issuance of shares | $   $ 4,780,000                  
Net proceeds from issuance of common stock | $   $ 4,250,000